logo
ResearchBunny Logo
Two-year safety outcomes of iPS cell-derived mesenchymal stromal cells in acute steroid-resistant graft-versus-host disease

Medicine and Health

Two-year safety outcomes of iPS cell-derived mesenchymal stromal cells in acute steroid-resistant graft-versus-host disease

K. Kelly, A. J. C. Bloor, et al.

This clinical trial found that 60% of participants with steroid-resistant acute graft-versus-host disease survived after two years of treatment with iPS cell-derived mesenchymal stromal cells (CYP-001). Impressively, there were no serious adverse events or safety concerns reported, indicating that this innovative therapy is both safe and well-tolerated. This research was conducted by Kilian Kelly, Adrian J. C. Bloor, James E. Griffin, Rohini Radia, David T. Yeung, and John E. J. Rasko.

00:00
00:00
Playback language: English
Abstract
This study reports the two-year safety and efficacy outcomes of a clinical trial involving 15 participants with steroid-resistant acute graft-versus-host disease (GvHD) treated with iPS cell-derived mesenchymal stromal cells (CYP-001). At the two-year mark, 60% of participants survived. Deaths were attributed to common complications in allogeneic hematopoietic stem cell transplantation recipients and were not considered treatment-related. No serious adverse events, tumors, or other safety concerns associated with CYP-001 were observed. The results suggest that systemic delivery of iPS cell-derived cells is safe and well-tolerated over a two-year period.
Publisher
Nature Medicine
Published On
May 22, 2024
Authors
Kilian Kelly, Adrian J. C. Bloor, James E. Griffin, Rohini Radia, David T. Yeung, John E. J. Rasko
Tags
graft-versus-host disease
iPS cell-derived
mesenchymal stromal cells
safety
efficacy
clinical trial
survival rate
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny